Meeder Asset Management’s Immunomedics Inc IMMU Stock Holding History

Meeder Asset Management’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-252	Closed	-$21K	–	2421
2020 Q3	$21K	Sell	252 -8,342	-97%	-$422K	﹤0.01%	1166
2020 Q2	$305K	Buy	+8,594	New	+$251K	0.02%	491
2020 Q1	–	Sell	-1,751	Closed	-$37K	–	2648
2019 Q4	$37K	Buy	+1,751	New	+$30.9K	﹤0.01%	1134
2018 Q3	–	Sell	-2,350	Closed	-$55.6K	–	1759
2018 Q2	$55.6K	Buy	+2,350	New	+$47.2K	﹤0.01%	733
2018 Q1	–	Sell	-107	Closed	-$1K	–	1818
2017 Q4	$1K	Buy	+107	New	+$1.26K	﹤0.01%	1621
2017 Q2	–	Sell	-419	Closed	-$3K	–	1991
2017 Q1	$3K	Sell	419 -261	-38%	-$1.32K	﹤0.01%	1307
2016 Q4	$2K	Buy	+680	New	+$2.01K	﹤0.01%	945

Meeder Asset Management's IMMU Position: Q4 2020 in Review

Meeder Asset Management sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 252 shares — an estimated $21K sold.

Meeder Asset Management first reported a position in IMMU in Q4 2016 and held it in 7 quarters. The position peaked at $305K in Q2 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Meeder Asset Management reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Meeder Asset Management sold 252 Immunomedics Inc shares in Q4 2020, an estimated $21K.
Meeder Asset Management first reported a position in Immunomedics Inc in Q4 2016 and held it in 7 quarters.
Meeder Asset Management's Immunomedics Inc position peaked at $305K in Q2 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Meeder Asset Management's 13F filing for Q4 2020, filed 9 Feb 2021.